Literature DB >> 29476445

Response to: the nearly complete TME quality conundrum.

M Pędziwiatr1,2, J Witowski3,4, P Major3,4, P Małczak3,4, M Mizera3, A Budzyński3,4.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 29476445      PMCID: PMC5862937          DOI: 10.1007/s10151-018-1758-5

Source DB:  PubMed          Journal:  Tech Coloproctol        ISSN: 1123-6337            Impact factor:   3.781


× No keyword cloud information.
Dear Sir, We would like to thank Prof. Bergamaschi and his colleagues for their commentary [1] on our systematic review and meta-analysis “There is no difference in outcome between laparoscopic and open surgery for rectal cancer: a systematic review and meta-analysis on short- and long-term oncologic outcomes” [2]. First of all, we appreciate Prof. Bergamaschi’s commentary since his reputation in the colorectal surgery community is indisputable. However, there are some points raised in his letter that must be addressed and explained because we believe that they are not entirely correct. We agree that there are no data from 1966 to 2005 included in our meta-analysis. The reason is simple: there were no studies published in that time frame that matched our inclusion criteria. As described in methodology section of the paper, we screened databases covering a period from January 1966 to October 2016. Similarly, a recent meta-analysis by Martinez-Perez et al. [3] searched for papers from 1995, yet included studies published from 2003 onward. A 2003 study by Araujo et al. [4] was not included because it did not report circumferential resection margin status, an inclusion criterion for our review. We would like to point readers (and Prof Bergamaschi) to Table 1 of our paper, where data on mean tumor distance from the anal verge are, in fact, reported. We did not provide data on completeness of mesorectal excision in 6 out of 11 studies, since that information was not provided by authors of included studies themselves. We performed a pooled analysis on data from five studies (all studies that reported this outcome) which did not reveal significant differences. Our grouping of “nearly complete” with “complete” mesorectal excision cases, based on Nagtegaal’s classification, was different from the meta-analysis by Martinez-Perez et al. In Nagtegaal’s original publication [5], the authors stated: “In our analysis we combined ‘optimal surgery’ cases and cases with nearly complete mesorectum, because we did not find statistical differences between these groups.” In Martinez-Perez’s meta-analysis, “nearly complete” and “incomplete” were incorrectly grouped together, as pointed out in the invited commentary to his review [6]. We decided to follow Nagtegaal’s original publication to reduce bias, and it turned out that this indeed changed the results! We also agree that we did not analyze the design of included studies or study sample calculations (which were not provided in all studies), and this might have some influence on the final meta-analysis. However, we believe this is of minor importance, especially since the risk of bias in included studies was considered low. In our understanding, our meta-analysis of well-conducted randomized controlled trials (RCTs) provides a high level of evidence on the similarity of total mesorectal excision. Both laparoscopic and open approaches to rectal cancer have their drawbacks. There is one certainty: open surgery has many limitations that cannot be overcome, whereas minimally invasive access, thanks to its ongoing technological advancement, is still evolving. Further comparison through RCTs of open and laparoscopic surgery is not needed in our opinion, and this is also evidenced by reluctance of patients to enroll in ongoing trials comparing open with laparoscopic surgery [7, 8]. Instead, we should wait for the results of studies comparing different laparoscopic/minimally invasive techniques to decide the future direction of rectal cancer surgery. This may not be using the robot to augment minimal access pelvic dissection [9], but maybe using a transanal TME when the COLOR III trial has reported [10]. Laparoscopic surgery has the same long-term oncological outcomes as open surgery in rectal cancer (leaving aside the other advantages of laparoscopic surgery). The debate should now focus around which is the best laparoscopic technique to use.
  10 in total

1.  Conventional approach x laparoscopic abdominoperineal resection for rectal cancer treatment after neoadjuvant chemoradiation: results of a prospective randomized trial.

Authors:  Sergio Eduardo Alonso Araujo; Afonso Henrique da Silva eSousa; Fábio Guilherme Caserta Marysael de Campos; Angelita Habr-Gama; Rodrigo Blanco Dumarco; Pedro Paulo de Paris Caravatto; Sergio Carlos Nahas; JoséHyppólito da Silva; Desidério Roberto Kiss; Joaquim José Gama-Rodrigues
Journal:  Rev Hosp Clin Fac Med Sao Paulo       Date:  2003-07-22

2.  Success rate of informed consent acquisition and factors influencing participation in a multicenter randomized controlled trial of laparoscopic versus open surgery for stage II/III colon cancer in Japan (JCOG0404).

Authors:  Tsuyoshi Etoh; Masafumi Inomata; Masahiko Watanabe; Fumio Konishi; Yutaka Kawamura; Yoshitake Ueda; Manabu Toujigamori; Hidefumi Shiroshita; Hiroshi Katayama; Seigo Kitano
Journal:  Asian J Endosc Surg       Date:  2015-07-15

3.  Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control.

Authors:  Iris D Nagtegaal; Cornelis J H van de Velde; Erik van der Worp; Ellen Kapiteijn; Phil Quirke; J Han J M van Krieken
Journal:  J Clin Oncol       Date:  2002-04-01       Impact factor: 44.544

4.  Nearly complete TME quality conundrum.

Authors:  A Dyatlov; M Gachabayov; R Bergamaschi
Journal:  Tech Coloproctol       Date:  2017-12-13       Impact factor: 3.781

Review 5.  There is no difference in outcome between laparoscopic and open surgery for rectal cancer: a systematic review and meta-analysis on short- and long-term oncologic outcomes.

Authors:  M Pędziwiatr; P Małczak; M Mizera; J Witowski; G Torbicz; P Major; M Pisarska; M Wysocki; A Budzyński
Journal:  Tech Coloproctol       Date:  2017-08-09       Impact factor: 3.781

6.  Effect of Robotic-Assisted vs Conventional Laparoscopic Surgery on Risk of Conversion to Open Laparotomy Among Patients Undergoing Resection for Rectal Cancer: The ROLARR Randomized Clinical Trial.

Authors:  David Jayne; Alessio Pigazzi; Helen Marshall; Julie Croft; Neil Corrigan; Joanne Copeland; Phil Quirke; Nick West; Tero Rautio; Niels Thomassen; Henry Tilney; Mark Gudgeon; Paolo Pietro Bianchi; Richard Edlin; Claire Hulme; Julia Brown
Journal:  JAMA       Date:  2017-10-24       Impact factor: 56.272

7.  Multicenter randomized controlled trial of conventional versus laparoscopic surgery for colorectal cancer within an enhanced recovery programme: EnROL.

Authors:  Robin H Kennedy; E Anne Francis; Rose Wharton; Jane M Blazeby; Philip Quirke; Nicholas P West; Susan J Dutton
Journal:  J Clin Oncol       Date:  2014-05-05       Impact factor: 44.544

Review 8.  Pathologic Outcomes of Laparoscopic vs Open Mesorectal Excision for Rectal Cancer: A Systematic Review and Meta-analysis.

Authors:  Aleix Martínez-Pérez; Maria Clotilde Carra; Francesco Brunetti; Nicola de'Angelis
Journal:  JAMA Surg       Date:  2017-04-19       Impact factor: 14.766

9.  Which Surgical Approach Is Best for Management of Rectal Cancer?: Does the End Point Tell How It Ends?

Authors:  Lakhbir Sandhu; George J Chang
Journal:  JAMA Surg       Date:  2017-04-19       Impact factor: 14.766

10.  COLOR III: a multicentre randomised clinical trial comparing transanal TME versus laparoscopic TME for mid and low rectal cancer.

Authors:  Charlotte L Deijen; Simone Velthuis; Alice Tsai; Stella Mavroveli; Elly S M de Lange-de Klerk; Colin Sietses; Jurriaan B Tuynman; Antonio M Lacy; George B Hanna; H Jaap Bonjer
Journal:  Surg Endosc       Date:  2015-11-04       Impact factor: 4.584

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.